EULAV ASSET MANAGEMENT – Vertex Pharmaceuticals Incorporated Transaction History
EULAV ASSET MANAGEMENT portfolio value:
$13.90M
portfolio value
EULAV ASSET MANAGEMENT quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -11.11% | -5.99K shares | -1.31M | $289.54 | 48.01K |
| Q2 2022 | share | Decrease | -10.00% | -5.99K shares | -441K | $281.79 | 54.00K |
| Q1 2022 | share | Decrease | -24.99% | -19.99K shares | -1.90M | $260.97 | 60.00K |
| Q4 2021 | share | Decrease | -25.93% | -28K shares | -2.02M | $222.45 | 80K |
| Q3 2021 | share | Decrease | -23.94% | -34K shares | -9.04M | $181.39 | 108K |
| Q2 2021 | share | Decrease | -5.33% | -8K shares | -3.60M | $201.63 | 142K |
| Q1 2021 | share | Increase | +92.31% | 72K shares | 13.79M | $214.89 | 150K |
| Q4 2020 | share | Increase | +67.74% | 31.5K shares | 5.78M | $236.34 | 78K |
| Q3 2020 | share | Decrease | -0.04% | -20 shares | -851K | $272.12 | 46.5K |
| Q2 2020 | share | Decrease | -8.78% | -4.48K shares | 1.37M | $290.31 | 46.52K |
| Q1 2020 | share | Decrease | -12.07% | -7K shares | -564K | $237.95 | 51K |
| Q4 2019 | share | Decrease | -15.94% | -11K shares | 1.00M | $218.95 | 58K |
| Q3 2019 | share | Increase | 0.00% | 69K shares | 11.69M | $169.42 | 69K |
| Q3 2018 | share | Decrease | -100.00% | -107K shares | -18.18M | $192.74 | 0 |
| Q2 2018 | share | Decrease | -8.55% | -10K shares | -883K | $169.96 | 107K |
| Q1 2018 | share | Decrease | -12.03% | -16K shares | -862K | $162.98 | 117K |
| Q4 2017 | share | Increase | +6.40% | 8K shares | 926K | $149.86 | 133K |
| Q3 2017 | share | Decrease | -3.10% | -4K shares | 2.38M | $152.04 | 125K |
| Q2 2017 | share | Decrease | -5.84% | -8K shares | 1.64M | $128.87 | 129K |
| Q1 2017 | share | Decrease | -3.52% | -5K shares | 4.52M | $109.35 | 137K |
| Q4 2016 | share | Decrease | -4.05% | -6K shares | -2.44M | $73.67 | 142K |
| Q3 2016 | share | Increase | +8.82% | 12K shares | 1.20M | $87.21 | 148K |
| Q2 2016 | share | Decrease | -6.85% | -10K shares | 93K | $86.02 | 136K |
| Q1 2016 | share | Increase | +20.66% | 25K shares | -3.61M | $79.49 | 146K |